Effects of nicotine on the cardiovascular system

Vascular Disease Prevention

Volumn 2, Issue 2, 2005, Pages 135-144

  Rejali, Maryam ^a   Rejali, Ali Reza ^a   Zhang, Lubo ^b   Yang, Shumei ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular system; Endothelial nitric oxide synthase; Endothelium; Nicotine; Nitric oxide

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NICOTINE; NITRIC OXIDE; SUPEROXIDE;

BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DRUG EFFECT; ERYTHROCYTE; HEMATOCRIT; HEMATOPOIESIS; HEMOSTASIS; HUMAN; ION PERMEABILITY; LEUKOCYTE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOGENESIS; UNITED STATES;

EID: 16444386140     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567270053507246     Document Type: Review

References (139)

1. Schenker M. Targeting Tobacco Use: The Nation's Leading Cause of Death. CDC. 2004.
2. Krupski WC. The peripheral vascular consequences of smoking. Ann Vasc Surg 1991; 5: 291-304.
3. Puranik R, Celermajer DS. Smoking and endothelial function. Prog Cardiovasc Dis 2003; 45: 443-58.
4. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998; 3: 21-8.
5. Omvik P. How smoking affects blood pressure. Blood Press 1996; 5: 71-7.
6. Moreno H Jr, Chalon S, Urae A, et al. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol 1998; 275: H1040-5.
7. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
8. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994; 90: 27-34.
9. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-100.
10. Heitzer T, Yla-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346-53.
11. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94: 6-9.
12. Motoyama T, Kawano H, Kugiyama K, et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997; 273: H1644-50.
13. Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium- dependent relaxation of saphenous vein. Br J Surg 1993; 80: 1242-5.
14. Higman DJ, Strachan AM, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996; 16: 546-52.
15. Albaugh G, Bellavance E, Strande L, et al. Nicotine Induces Mononuclear Leukocyte Adhesion and Expression of Adhesion Molecules, VCAM and ICAM, in Endothelial Cells In Vitro. Ann Vasc Surg 2004; 18: 302-7.
16. McVeigh GE, Lemay L, Morgan D, Cohn JN. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996; 78: 668-72.
17. Jones MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for healthcare professionals. Circulation 1992; 86: 1664-9.
18. Hecht SS, Chen CHB, Hoffmann D. Tobacco-specific nitrosamines: Occurrence, formation, carcinogenicity, and metabolism. Acc Chem Res 1979; 12: 92-8.
19. Hoffmann D, Wynder EL. A study of tobacco carcinogenesis. XI. Tumor initiators, tumor accelerators, and tumor promoting activity of condensate fractions. Cancer 1971; 27: 848-64.
20. Lekakis J, Papamichael C, Vemmos C, Stamatelopoulos K, Voutsas A, Stamatelopoulos S. Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects. Am J Cardiol 1998; 81: 1225-8.
21. Hutchison SJ, Sievers RE, Zhu BQ, et al. Secondhand tobacco smoke impairs rabbit pulmonary artery endothelium-dependent relaxation. Chest 2001; 120: 2004-12.
22. Stefanadis C, Vlachopoulos C, Tsiamis E, et al. Unfavorable effects of passive smoking on aortic function in men. Ann Intern Med 1998; 128: 426-34.
23. Mayhan WG, Sharpe GM. Effect of cigarette smoke extract on arteriolar dilatation in vivo. J Appl Physiol 1996; 81: 1996-2003.
24. Tanaka T, Oka Y, Tawara I, Sada T, Kira Y. Acute effects of nicotine content in cigarettes on coronary flow velocity and coronary flow reserve in men. Am J Cardiol 1998; 82: I275-8, A9.
25. Rosa GM, Lucas GQ, Lucas ON. Study of the crevicular fluid flow rate in smokers. Acta Odontol Latinoam 2000; 13: 51-60.
26. Mayhan WG, Sharpe GM, Anding P. Agonist-induced release of nitric oxide during acute exposure to nicotine. Life Sci 1999; 65: 1829-37.
27. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39: 251-6.
28. Chalon S, Moreno H Jr, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000; 67: 391-7.
29. Black CE, Huang N, Neligan PC, et al. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1097-104.
30. Wang R, Wang Z. Three different vasoactive responses of rat tail artery to nicotine. Can J Physiol Pharmacol 2000; 78: 20-8.
31. Toda N, Yoshida K, Okamura T. Involvement of nitroxidergic and noradrenergic nerves in the relaxation of dog and monkey temporal veins. J Cardiovasc Pharmacol 1995; 25: 741-7.
32. Waeber B, Schaller MD, Nussberger J, Bussien JP, Hofbauer KG, Brunner HR. Skin blood flow reduction induced by cigarette smoking: role of vasopressin. Am J Physiol 1984; 247: H895-901.
33. Toda N. Mediation by nitric oxide of neurally-induced human cerebral artery relaxation. Experientia 1993; 49: 51-3.
34. Iida M, Iida H, Dohi S, Takenaka M, Fujiwara H. Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo. Stroke 1998; 29: 1656-65.
35. Zhang W, Edvinsson L, Lee TJ. Mechanism of nicotine-induced relaxation in the porcine basilar artery. J Pharmacol Exp Ther 1998; 284: 790-7.
36. Okamura T, Ayajiki K, Uchiyama M, Kagami K, Toda N. Mechanisms underlying constrictor and dilator responses to perivascular nerve stimulation in canine lingual arteries. Eur J Pharmacol 1998; 354: 43-50.
37. Uchiyama M, Okamura T, Uehara M, Toda N. Analysis of the vasodilator nerve function by nicotine in isolated dog skin artery Eur J Pharmacol 1997; 321: 19-25.
38. Smith DA, Hoffman AF, David DJ, Adams CE, Gerhardt GA. Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci Lett 1998; 255: 127-30.
39. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998; 19: 819-25.
40. Conklin BS, Surowiec SM, Ren Z, et al. Effects of nicotine and cotinine on porcine arterial endothelial cell function. J Surg Res 2001; 95: 23-31.
41. Tonnessen BH, Severson SR, Hurt RD, Miller VM. Modulation of nitric-oxide synthase by nicotine. J Pharmacol Exp Ther 2000; 295: 601-6.
42. Zhang S, Day I, Ye S. Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis 2001; 154: 277-83.
43. Zhang S, Day IN, Ye S. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomics 2001; 5: 187-92.
44. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 1998; 84: 2089-98.
45. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS. Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 1999; 82: 43-7.
46. Waggoner SE, Wang X. Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells. Gynecol Oncol 1994; 55: 91-5.
47. Boutherin-Falson O, Blaes N. Nicotine increases basal prostacyclin production and DNA synthesis of human endothelial cells in primary cultures. Nouv Rev Fr Hematol 1990; 32: 253-8.
48. Conklin BS, Zhao W, Zhong DS, Chen C. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 2002; 160: 413-8.
49. Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997; 150: 1673-85.
50. Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16.
51. Albaugh G, Kann B, Strande L, Vemulapalli P, Hewitt C, Alexander JB. Nicotine induces endothelial TNF-alpha expression, which mediates growth retardation in vitro. J Surg Res 2001; 99: 381-4.
52. Lin E, Lowry SF, Calvano SE (Eds.). Principles of Surgery. 7th ed. New York. McGraw-Hill 1998; 14-15.
53. Ko Y, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. Mol Cell Probes 1999; 13: 203-11.
54. Hakki A, Friedman H, Pross S. Nicotine modulation of apoptosis in human coronary artery endothelial cells. Int Immunopharmacol 2002; 2: 1403-9.
55. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb 1992; 12: 1305-12.
56. Tithof PK, Elgayyar M, Schuller HM, Barnhill M, Andrews R. 4(methylnitrosamino)-1-(3-pyridyl)-1-butiinone, a nicotine derivative, induces apoptosis of endothelial cells. Am J Physiol Heart Circ Physiol 2001; 281: H1946-54.
57. Pittilo RM. Cigarette smoking, endolhelial injury and cardiovascular disease. Int J Exp Pathol 2000; 81: 219-30.
58. Zimmerman M, McGeachie J. The effect of nicotine on aortic endothelium. A quantitative ultrastructural study. Atherosclerosis 1987; 63: 33-41.
59. Pittilo RM, Bull HA, Gulati S, et al. Nicotine and cigarette smoking: effects on the ultrastructure of aortic endothelium. Int J Exp Pathol 1990; 71: 573-86.
60. th Edition. Upper Saddle River, Prentice Hall. 1999; 345-6.
61. Berlin I, Spreux-Varoquaux O, Launay JM. Platelet monoamine oxidase B activity is inversely associated with plasma cotinine concentration. Nicotine Tob Res 2000; 2: 243-6.
62. Erikssen G, Thaulow E, Sandvik L, Stormorken H, Erikssen J. Haematocrit: a predictor of cardiovascular mortality? J Intern Med 1993; 234: 493-9.
63. Ludviksdottir D, Blondal T, Franzon M, Gudmundsson TV, Sawe U. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 1999; 246: 61-6.
64. Whitehead TP, Robinson D, Allaway SL, Hale AC. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin Lab Haematol 1995; 17: 131-8.
65. Khaldoyanidi S, Sikora L, Orlovskaya I, Matrosova V, Kozlov V, Sriramarao P. Correlation between nicotine-induced inhibition of hematopoiesis and decreased CD44 expression on bone marrow stromal cells. Blood 2001; 98: 303-12.
66. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76: 6-14.
67. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; 2: 986-8.
68. Mileikowsky GN, Nadler JL, Huey F, Francis R, Roy S. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives. Am J Obstet Gynecol 1988; 159: 1547-52.
69. Roy S. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives. Am J Obstet Gynecol. 1999; 180(6 Pt 2):S364-8.
70. Mustard JF, Packham MA. Platelets, thrombosis and drugs. Drugs 1975; 9: 19-76.
71. Folts JD, Gering SA, Laibly SW, Bertha BG, Bonebrake FC, Keller JW. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis. Adv Exp Med Biol 1990; 273: 339-58.
72. Renaud S, Blache D, Dumont E, Thevenon C, Wissendanger T. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide. Clin Pharmacol Ther 1984; 36: 389-95.
73. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003; 46(1): 11-29.
74. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982; 65: 465-70.
75. Blache D, Bouthillier D, Davignon J. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 1992; 93: 179-88.
76. Hioki H, Aoki N, Kawano K, et al. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22: 56-61.
77. Racke K, Schworer H, Simson G. Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers. Clin Investig 1992; 70: 201-4.
78. Rausch JL, Fefferman M, Ladisich-Rogers DG, Menard M. Effect of nicotine on human blood platelet serotonin uptake and efflux. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 907-16.
79. Zidovetzki R, Chen P, Fisher M, Hofman FM, Faraci FM. Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke 1999; 30: 651-5.
80. th Edition. New York, John Wiley and Sons. 2000; 627-54
81. Becker BF, Terres W, Kratzer M, Gerlach E. Blood platelet function after chronic treatment of rats and guinea pigs with nicotine. Klin Wochenschr 1988, 66 Suppl. 11: 28-36.
82. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation 2004; 109: 78-83.
83. Whiss PA, Lundahl TH, Bengtsson T, Lindahl TL, Lunell E, Larsson R. Acute effects of nicotine, infusion on platelets in nicotine users with normal and impaired renal function. Toxicol Appl Pharmacol 2000; 163; 95-104.
84. Davis JW, Arnold J. Time course of some effects of cigarette smoking on platelets. J Intern Med 1992; 231: 31-6.
85. Blann AD, Steele C, McCollum CN. The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost 1997; 78: 1093-6.
86. Nowak J, Andersson K, Benthin G, Chen J, Karlberg KE, Sylven C. Effect of nicotine infusion in humans on platelet aggregation and urinary excretion of a major thromboxane metabolite. Acta Physiol Scand 1996; 157: 101-7.
87. Pfueller SL, Burns P, Mak K, Firkin BG. Effects of nicotine on platelet function. Haemostasis 1988; 18: 163-9.
88. 2+ channels in cerebral arterioles. Circ Res 2001; 88: 359-65.
89. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 1993; 265: C299-303.
90. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1994; 91: 7583-7.
91. Ishikawa T, Hume JR, Keef KD. Regulation of Ca2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res 1993; 73: 1128-37.
92. Tewari K, Simard JM. Sodium nitroprusside and cGMP decrease Ca2+ channel availability in basilar artery smooth muscle cells. Pflugers Arch 1997; 433: 304-11.
93. Thorin E, Henrion D, Oster L, et al. Vascular calcium overload produced by administration of vitamin D3 and nicotine in rats. Changes in tissue calcium levels, blood pressure, and pressor responses to electrical stimulation or norepinephrine in vivo. J Cardiovasc Pharmacol 1990; 16: 257-66.
94. Henrion D, Chillon JM, Hoffman M, Capdeville-Atkinson C, Atkinson J. Decrease in endothelium-dependent relaxation in the mesenteric arterial bed following vascular calcium overload produced by vitamin D3 and nicotine in rats. Life Sci 1991; 49:575-86.
95. Tang G, Hanna ST, Wang R. Effects of nicotine on K+ channel currents in vascular smooth muscle cells from rat tail arteries. Eur J Pharmacol 1999; 364: 247-54.
96. Mayhan WG, Sharpe GM. Acute and chronic treatment with nicotine impairs reactivity of arterioles in response to activation of potassium channels. J Cardiovasc Pharmacol 2002; 39: 695-703.
97. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 2003; 179: 217-23.
98. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000; 102: 1233-8.
99. Mayhan WG, Sharpe GM. Superoxide dismutase restores endothelium-dependent arteriolar dilatation during acute infusion of nicotine. J Appl Physiol 1998; 85: 1292-8.
100. Mayhan WG, Sharpe GM. Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase. J Appl Physiol 1999; 86: 1126-34.
101. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals. Circulation 1994; 89: 1272-81.
102. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-5.
103. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 2003; 284: H528-34.
104. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitricoxide synthase. J Biol Chem 1997; 272: 12030-4.
105. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 2001; 281: H981-6.
106. Aronow WS, Dendinger J, Rokaw SN. Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris. Ann Intern Med 1971; 74: 697-702.
107. Tachmes L, Fernandez RJ, Sackner MA. Hemodynamic effects of smoking cigarettes of high and low nicotine content. Chest 1978; 74: 243-6.
108. Kaijser L, Berglund B. Effect of nicotine on coronary blood-flow in man. Clin Physiol 1985; 5: 541-52.
109. Kilaru S, Frangos SG, Chen AH, et al. Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 2001; 193: 538-46.
110. Hawkins BT, Brown RC, Davis TP. Smoking and ischemic stroke: a role for nicotine? Trends Pharmacol Sci 2002; 23: 78-82.
111. Clement DL. Medical treatment of peripheral artery occlusive disease (PAOD). Acta Chir Belg 2000; 100: 190-3.
112. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001; 21: 274-301.
113. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. St. Louis, Wiley Inc. 1997; 1024-91.
114. Zhu BQ, Sun YP, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 1994; 89: 1282-90.
115. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 2001; 158: 257-67.
116. Villarreal FJ, Hong D, Omens J. Nicotine-modified postinfarction left ventricular remodeling. Am J Physiol 1999; 276: H1103-6.
117. Kimmel SE, Berlin JA, Miles C, Jaskowiak J, Carson JL, Strom BL. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001; 37: 1297-302.
118. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac Arrhythmias Following Intravenous Nicotine: Experimental Study in Dogs. J Cardiovasc Pharmacol Ther 1997; 2: 291-298.
119. Hayashi H, Omichi C, Miyauchi Y, et al. Age-related sensitivity to nicotine for inducible atrial tachycardia and atrial fibrillation. Am J Physiol Heart Circ Physiol 2003; 285: H2091-8.
120. Choragudi NL, Aronow WS, DeLuca AJ. Nicotine gum-induced atrial fibrillation. Heart Dis 2003; 5: 100-1.
121. Yashima M, Ohara T, Cao JM, et al. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol 2000; 278: H2124-33.
122. Ohara T, Yashima M, Hamzei A, et al. Nicotine Increases Spatiotemporal Complexity of Ventricular Fibrillation Wavefront on the Epicardial Border Zone of Healed Canine Infarcts. J Cardiovasc Pharmacol Ther 1999; 4: 121-127.
123. Anderson TJ, Gerhard MD, Meredith IT, et al. Systematic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995; 75: 71B-74B.
124. Cluette-Brown J, Mulligan J, Doyle K, Hagan S, Osmolski T, Hojnacki J. Oral nicotine induces an atherogenic lipoprotein profile. Proc Soc Exp Biol Med 1986; 182: 409-13.
125. Gillespie MN, Owasoyo JO, Kiritsy-Roy JA, O'Connor WN, Van Loon GR. Exaggerated nicotine-induced norepinephrine release from atherosclerotic rabbit hearts. Toxicology 1985; 37: 147-57.
126. Carty CS, Huribal M, Marsan BU, Ricotta JJ, Dryjski M. Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells. J Vasc Surg 1997; 25: 682-8.
127. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med 1997; 26: 412-7.
128. Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108-12.
129. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-8.
130. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 1994; 107: 1050-8.
131. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 1995; 76: 30-9.
132. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995; 15: 1652-9.
133. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
134. Marks DS, Vita JA, Folts JD, Keaney JF Jr, Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995; 96: 2630-8.
135. Yang ZH, Stulz P, von Segesser L, Bauer E, Turina M, Luscher TF. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991; 337: 939-43.
136. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7.
137. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 1994; 267: C1405-13.
138. Sarkar R, Webb RC, Stanley JC. Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 1995; 118: 274-9.
139. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest 1995; 96: 141-9.